Axsome Therapeutics, Inc. (AXSM)

178.70 -3.94 (-2.16%) USD  |  NASDAQ  |  Jan 02, 16:00
178.74 +0.04 (+0.02%) After-Hours: 20:00
More

Axsome Therapeutics Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for AXSM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Fortress Biotech, Inc. Upgrade
TG Therapeutics, Inc. Upgrade
Karyopharm Therapeutics, Inc. Upgrade